BBI Solutions

BBI Solutions is a long-established, privately-held reagent and contract manufacturing specialist serving the global IVD and life sciences markets. The company operates on a B2B services and product model, generating revenue from the sale of its catalog reagents and from high-value services including antibody development, protein customization, gold conjugation, and lateral flow test contract manufacturing. With ISO 13485 certification and a strong focus on scalability and regulatory support, BBI is a critical supply chain partner for diagnostic companies, particularly in the high-volume glucose monitoring and lateral flow assay segments, powering billions of tests annually.

Integrated reagent development and manufacturing platform encompassing antibody development (hybridoma), enzyme fermentation (up to 5,000L), gold nanoparticle conjugation (≤8% CV), and lateral flow device contract manufacturing.

BBI competes with other large reagent suppliers (e.g., Meridian Life Science, Fitzgerald Industries) and CDMOs in the diagnostics space. Its competitive advantages are its long history, deep expertise in gold conjugation and enzymes, integrated service offerings from development to manufacturing, and ISO 13485-certified scale, which is critical for regulated IVD clients.